Cefixime trihydrate PurCert Secondary Reference Standard (CRM) [Includes characterization data]
PurCert
Properties
| Assay Purity | >= 98 % |
| M pt. | 218-225 |
| Form | Powder |
Safety Information
| Hazard Statement(s) | H317,H334 |
| Precautionary Statement | P261 - P272 - P280 - P284 - P302 + P352 - P333 + P313 |
| GHS Pictogram |
|
| Signal word | Danger |
| HS Code | 2941906000 |
| Storage Temp. | 2-8°C |
| Storage Class | 11 - Combustible Solids |
Description
Application
It is administered orally in tablets capsules or suspensions to treat infections including uncomplicated gonorrhea pharyngitis tonsillitis acute exacerbations of chronic bronchitis urinary tract infections and otitis media caused by susceptible Gram-negative and Gram-positive bacteria.
Purpose
Cefixime trihydrate inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins effective against pathogens like Streptococcus pneumoniae Haemophilus influenzae Moraxella catarrhalis and Neisseria gonorrhoeae with enhanced -lact
General Description
Cefixime trihydrate is the trihydrate form of the third-generation cephalosporin antibiotic cefixime with molecular formula CHNOS (MW 507.50 gmol CAS 125110-14-7) featuring a -lactam ring fused to a dihydrothiazine ring with a (2Z)-2-(2-amino-4-thiazolyl)-2-[(carboxymethoxy)imino]acetyl side chain at C-7 and a vinyl group at C-3 appearing as a white to off-white crystalline powder.
Documents
| SDS | |
| COA | |
| Specification | |
| Bulk quote order form | |
| Sample COA |
